Refractive Surgery and Optive Compatibility Study

Phase 4CompletedNCT00469157

Innovative Medical92 enrolled

Overview

To assess the compatibility of Optive with refractive surgery (PRK and LASIK) post-operatively.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Dry Eye Syndromes

Interventions

OptiveDRUG

Optive 30ml- (in the eye) Instill one in each eye twice daily starting one week after surgery

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Men and women 18 and over * Patients undergoing refractive surgery Exclusion Criteria: * Concurrent ocular conditions or pathology that could affect patient's ability to complete study * Concurrent use of topical medications other than study medications * Use of systemic medications with ocular drying sequelae: * Antihistamines * Decongestants * Antispasmotics * Antidepressants

Locations (1)

TLC

Fullerton, California, United States

Outcomes

Primary Outcomes

Assess compatibility

Time frame: 8 months

Secondary Outcomes

comfort

Time frame: 8 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.